Seòmar agus comataidhean

The Scottish Government has agreed with NHS Highland that due to exceptional circumstances there, a mixed model of vaccine delivery can be put in place. This will be a hybrid model for vaccine delivery in which NHS Highland will also continue to provide some vaccination programmes.

The Scottish Government draft budget 2025-26 has been informed by planning forecasts provided by the Thrombectomy Advisory Group (TAG). Clinicians and third sector organisations, as well as NHS planning colleagues, are represented on the TAG and the information provided by them helps to inform decisions taken by the National Thrombectomy Programme Board.

Work is ongoing to establish how the £16 million funding announced in the Scottish budget, subject to parliamentary scrutiny, will be best used to maximise the number of patients able to benefit from thrombectomy.

It is forecast that £3.185m will have been spent by the end of March 2025 for activity related to the aims in the Neurological Care and Support in Scotland: A Framework for Action 2020 – 2025.

The Framework was published in 2019 and despite the extensive disruption to health and social care services during the pandemic, and accompanying pressure on Scottish Government and health board priorities, we sustained our focus and efforts to deliver the commitments of the Framework.

Actions will continue in the financial year 2025-26 for which the budget is still to be passed. We are asking Parliament to unite behind the Budget to ensure this funding reaches the people who need it.

The Scottish Government draft budget 2025-26 has been informed by planning forecasts provided by the Thrombectomy Advisory Group (TAG). Clinicians and third sector organisations, as well as NHS planning colleagues, are represented on the TAG and the information provided by them helps to inform decisions taken by the National Thrombectomy Programme Board.

Work is ongoing to establish how the £16 million funding announced in the Scottish budget, subject to parliamentary scrutiny, will be best used to maximise the number of patients able to benefit from thrombectomy.

Neurology trainees are provided with training in immunology and virology. The curriculum for neurology training, published by the Joint Royal Colleges of Physicians Training Board, includes Capabilities in Practice (CiPs) on managing inflammatory and infectious disorders.

These CiPs make clear expectations upon neurology trainees regarding:

• understanding of the underlying anatomy and pathophysiology of inflammatory and infectious diseases of the nervous system, including the treatments and their side effects
• ability to select, request and interpret relevant investigations including serology, genetic testing, imaging of the brain and spine, neurophysiology, tissue culture and histology in order to diagnose and manage such disorders
• ability to work with other relevant clinicians both in treating and monitoring patients and in referring them to other disciplines as appropriate.

There is robust educational Governance through NHS Education Scotland (NES) for neurology training in Scotland. NES does not consider it necessary to require neurologists to be experts in either immunology or virology, but to be able to clinically assess, investigate and manage people with neuroimmunological conditions and neuroinfectious disease using an evidence-based approach.

Work is ongoing to establish how the £16 million funding announced in the draft Scottish budget will be best used to maximise the number of patients able to benefit from thrombectomy.

The new Scottish Budget was presented to Parliament on 4 December 2024 with £16 million allocated to the further development of the thrombectomy service and stroke policy. This details Scottish Ministers spend proposals for the year ahead and the Scottish Parliament will then scrutinise this information through the Scottish Budget Bill. Further details on the Scottish Budget and the Health and Social Care portfolio budget Finance can be found at; Scottish Budget 2025 to 2026.

The latest data received by the Scottish Government from NHS Education for Scotland (NES) is as follows:

a) WTE Applied Psychologists working in Neuropsychology in NHS Scotland as of 30 September 2024:

As set out in the answer to question S6W-33241 on 24 January 2025, Screening Oversight and Assurance Scotland are developing a business case for the implementation of a targeted lung screening programme, which is expected by the end of February 2025.

Following receipt, the Scottish Screening Committee will be convened to discuss its findings and consider next steps.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

There are no plans to expand eligibility of The Young Patients Family Fund (YPFF) at this time.

In addition to support available under the YPFF, financial support for travel to hospital is available via the patient travel expenses reimbursement schemes. Under those schemes, patients and authorised escorts can reclaim reasonable costs of travel associated with attending a hospital appointment, in line with eligibility criteria and medical requirements.

The largest proportion of funding has been awarded to projects that improve services for all or more than one neurological condition, including services for carers. Direct investment was also made to projects for the following specific conditions:

• Acquired Brain Injury
• Cerebral Palsy
• Epilepsy
• Functional Neurological Disorder (FND)
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
• Migraine
• Multiple Sclerosis (MS)
• Parkinson’s Disease
• Progressive Supranuclear Palsy (PSP)
• Psychogenic Non-Epileptic Seizures
• Spina bifida/ hydrocephalus

A full list of projects funded through the Neurological Framework can be found here.